Stay updated on Avapritinib vs Regorafenib in GIST Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.

Latest updates to the Avapritinib vs Regorafenib in GIST Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check8 days agoChange DetectedNo additions or deletions were detected; the page content appears unchanged.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be an internal versioning change and does not alter study data or user-facing content.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 on the page.SummaryDifference0.0%

- Check52 days agoChange DetectedNo additions or deletions were detected on the page; the study details and related sections appear unchanged.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision: v3.4.2 has replaced v3.4.1 on the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Avapritinib vs Regorafenib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.